Concepts (141)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Spinal Cord Injuries | 8 | 2009 | 930 | 0.920 |
Why?
|
Autoantibodies | 3 | 2010 | 2036 | 0.560 |
Why?
|
Anesthetics | 1 | 2021 | 538 | 0.530 |
Why?
|
Central Nervous System | 3 | 2010 | 1354 | 0.440 |
Why?
|
B-Lymphocytes | 4 | 2010 | 4664 | 0.430 |
Why?
|
Anesthesia | 2 | 2021 | 1548 | 0.380 |
Why?
|
Neuroimmunomodulation | 2 | 2008 | 152 | 0.350 |
Why?
|
Nerve Regeneration | 3 | 2009 | 791 | 0.340 |
Why?
|
Myelitis | 2 | 2008 | 53 | 0.330 |
Why?
|
Chemotaxis, Leukocyte | 2 | 2008 | 675 | 0.320 |
Why?
|
Trauma, Nervous System | 1 | 2007 | 36 | 0.300 |
Why?
|
Peripheral Nervous System | 1 | 2007 | 150 | 0.270 |
Why?
|
Autoimmune Diseases of the Nervous System | 1 | 2006 | 67 | 0.270 |
Why?
|
Spinal Cord | 5 | 2009 | 1807 | 0.260 |
Why?
|
Lymphocyte Activation | 4 | 2010 | 5519 | 0.250 |
Why?
|
Autoimmunity | 2 | 2010 | 1348 | 0.240 |
Why?
|
Recovery of Function | 4 | 2009 | 2924 | 0.230 |
Why?
|
Axons | 4 | 2009 | 1681 | 0.230 |
Why?
|
Antigens | 1 | 2007 | 1462 | 0.200 |
Why?
|
Lymphocytes | 1 | 2008 | 2614 | 0.180 |
Why?
|
Motor Activity | 4 | 2009 | 2714 | 0.180 |
Why?
|
Stromal Cells | 1 | 2004 | 1353 | 0.170 |
Why?
|
Vaccines | 1 | 2007 | 817 | 0.160 |
Why?
|
Macrophages | 5 | 2011 | 5655 | 0.150 |
Why?
|
Brain-Derived Neurotrophic Factor | 1 | 2001 | 604 | 0.150 |
Why?
|
Bone Marrow Transplantation | 1 | 2004 | 2763 | 0.140 |
Why?
|
Polyethylene Glycols | 1 | 2001 | 1181 | 0.130 |
Why?
|
Pneumonectomy | 1 | 2021 | 1093 | 0.120 |
Why?
|
Microglia | 4 | 2011 | 1261 | 0.120 |
Why?
|
Hindlimb | 3 | 2010 | 505 | 0.120 |
Why?
|
Encephalomyelitis, Autoimmune, Experimental | 2 | 2009 | 834 | 0.110 |
Why?
|
Excitatory Amino Acids | 1 | 2011 | 18 | 0.100 |
Why?
|
Mice, Inbred C57BL | 9 | 2011 | 21821 | 0.100 |
Why?
|
Length of Stay | 2 | 2021 | 6294 | 0.090 |
Why?
|
Behavior, Animal | 3 | 2010 | 1882 | 0.090 |
Why?
|
Complement C1q | 1 | 2009 | 92 | 0.090 |
Why?
|
Spinal Cord Ischemia | 1 | 2010 | 93 | 0.090 |
Why?
|
Paralysis | 1 | 2010 | 249 | 0.080 |
Why?
|
Spinal Cord Diseases | 1 | 2011 | 299 | 0.080 |
Why?
|
Hemoglobins | 1 | 2014 | 1532 | 0.080 |
Why?
|
Axotomy | 1 | 2007 | 74 | 0.070 |
Why?
|
Oligoclonal Bands | 1 | 2006 | 16 | 0.070 |
Why?
|
Freund's Adjuvant | 1 | 2007 | 139 | 0.070 |
Why?
|
Myelin-Associated Glycoprotein | 1 | 2007 | 113 | 0.070 |
Why?
|
Animals | 15 | 2011 | 168561 | 0.070 |
Why?
|
Wounds, Nonpenetrating | 2 | 2004 | 794 | 0.070 |
Why?
|
Myelin Proteins | 1 | 2007 | 215 | 0.070 |
Why?
|
Glutamic Acid | 1 | 2011 | 1167 | 0.070 |
Why?
|
Receptors, Fc | 1 | 2009 | 540 | 0.070 |
Why?
|
Disease Models, Animal | 7 | 2011 | 18006 | 0.060 |
Why?
|
Facial Nerve | 1 | 2007 | 271 | 0.060 |
Why?
|
Cross Reactions | 1 | 2006 | 841 | 0.060 |
Why?
|
Aorta, Thoracic | 1 | 2010 | 1080 | 0.060 |
Why?
|
Nucleic Acids | 1 | 2006 | 181 | 0.060 |
Why?
|
Nerve Degeneration | 1 | 2008 | 748 | 0.060 |
Why?
|
Mice | 9 | 2011 | 81045 | 0.060 |
Why?
|
Mice, Knockout | 2 | 2009 | 14554 | 0.060 |
Why?
|
Lung | 1 | 2021 | 9826 | 0.050 |
Why?
|
Immunization, Passive | 1 | 2004 | 625 | 0.050 |
Why?
|
Adaptation, Physiological | 1 | 2008 | 1310 | 0.050 |
Why?
|
Choline O-Acetyltransferase | 1 | 2001 | 150 | 0.050 |
Why?
|
Rats, Wistar | 1 | 2004 | 1902 | 0.050 |
Why?
|
Injections, Spinal | 1 | 2001 | 303 | 0.050 |
Why?
|
Rats | 4 | 2009 | 24265 | 0.050 |
Why?
|
Mice, Inbred BALB C | 1 | 2009 | 6382 | 0.050 |
Why?
|
T-Lymphocytes | 3 | 2010 | 10163 | 0.050 |
Why?
|
Drug Delivery Systems | 1 | 2010 | 2217 | 0.040 |
Why?
|
Nerve Tissue Proteins | 2 | 2011 | 4465 | 0.040 |
Why?
|
Immunoglobulin G | 1 | 2009 | 4554 | 0.040 |
Why?
|
Ganglia, Spinal | 2 | 2009 | 517 | 0.040 |
Why?
|
Multiple Sclerosis | 1 | 2010 | 3076 | 0.030 |
Why?
|
Female | 11 | 2014 | 379592 | 0.030 |
Why?
|
Cells, Cultured | 2 | 2009 | 19223 | 0.030 |
Why?
|
Graft Survival | 1 | 2004 | 3733 | 0.030 |
Why?
|
Lupus Erythematosus, Systemic | 1 | 2006 | 2099 | 0.030 |
Why?
|
Myelin Sheath | 2 | 2009 | 652 | 0.030 |
Why?
|
Immunohistochemistry | 2 | 2010 | 11363 | 0.030 |
Why?
|
DNA-Binding Proteins | 2 | 2009 | 9639 | 0.030 |
Why?
|
Lipopolysaccharides | 2 | 2011 | 2211 | 0.030 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2009 | 8925 | 0.030 |
Why?
|
Vaccination | 1 | 2004 | 3256 | 0.030 |
Why?
|
Cystine | 1 | 2011 | 95 | 0.020 |
Why?
|
Constriction | 1 | 2010 | 181 | 0.020 |
Why?
|
Humans | 6 | 2021 | 742088 | 0.020 |
Why?
|
Subclavian Artery | 1 | 2010 | 129 | 0.020 |
Why?
|
Time Factors | 3 | 2009 | 40054 | 0.020 |
Why?
|
Acid-Base Equilibrium | 1 | 2010 | 185 | 0.020 |
Why?
|
Quinoxalines | 1 | 2011 | 288 | 0.020 |
Why?
|
Wallerian Degeneration | 1 | 2009 | 70 | 0.020 |
Why?
|
Chondroitin Sulfate Proteoglycans | 1 | 2009 | 130 | 0.020 |
Why?
|
Blood Gas Analysis | 1 | 2010 | 381 | 0.020 |
Why?
|
Zymosan | 1 | 2009 | 124 | 0.020 |
Why?
|
Excitatory Amino Acid Antagonists | 1 | 2011 | 449 | 0.020 |
Why?
|
Cell Survival | 2 | 2009 | 5872 | 0.020 |
Why?
|
Glutathione | 1 | 2011 | 586 | 0.020 |
Why?
|
Postoperative Period | 1 | 2014 | 1839 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2001 | 10943 | 0.020 |
Why?
|
Surgical Instruments | 1 | 2010 | 394 | 0.020 |
Why?
|
Antibodies, Monoclonal, Murine-Derived | 1 | 2010 | 694 | 0.020 |
Why?
|
Cell Differentiation | 1 | 2004 | 11470 | 0.020 |
Why?
|
Oxidation-Reduction | 1 | 2011 | 2187 | 0.020 |
Why?
|
Macrophage Activation | 1 | 2009 | 558 | 0.020 |
Why?
|
Cell Count | 1 | 2009 | 1831 | 0.020 |
Why?
|
Sensory Receptor Cells | 1 | 2009 | 487 | 0.020 |
Why?
|
Calcium-Binding Proteins | 1 | 2009 | 1081 | 0.010 |
Why?
|
Postoperative Care | 1 | 2010 | 1484 | 0.010 |
Why?
|
Reperfusion Injury | 1 | 2010 | 1025 | 0.010 |
Why?
|
Treatment Outcome | 2 | 2014 | 62966 | 0.010 |
Why?
|
Microfilament Proteins | 1 | 2009 | 1152 | 0.010 |
Why?
|
Cell Death | 1 | 2009 | 1695 | 0.010 |
Why?
|
Animals, Newborn | 1 | 2009 | 2723 | 0.010 |
Why?
|
Histocompatibility Antigens Class II | 1 | 2007 | 1470 | 0.010 |
Why?
|
Oxygen | 1 | 2014 | 4169 | 0.010 |
Why?
|
Rats, Inbred Lew | 1 | 2004 | 1161 | 0.010 |
Why?
|
Phagocytosis | 1 | 2007 | 1538 | 0.010 |
Why?
|
Immunologic Factors | 1 | 2010 | 1575 | 0.010 |
Why?
|
Gene Expression Regulation | 2 | 2011 | 12071 | 0.010 |
Why?
|
Neurons | 2 | 2011 | 9325 | 0.010 |
Why?
|
Hemodynamics | 1 | 2010 | 4197 | 0.010 |
Why?
|
Analysis of Variance | 1 | 2009 | 6365 | 0.010 |
Why?
|
Monocytes | 1 | 2009 | 2593 | 0.010 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2007 | 4751 | 0.010 |
Why?
|
Kaplan-Meier Estimate | 1 | 2010 | 6534 | 0.010 |
Why?
|
Cardiac Surgical Procedures | 1 | 2014 | 3526 | 0.010 |
Why?
|
Rats, Sprague-Dawley | 1 | 2009 | 8300 | 0.010 |
Why?
|
Flow Cytometry | 1 | 2007 | 5975 | 0.010 |
Why?
|
Mice, Transgenic | 1 | 2009 | 9735 | 0.010 |
Why?
|
Male | 3 | 2014 | 349538 | 0.010 |
Why?
|
Cerebral Cortex | 1 | 2009 | 5705 | 0.010 |
Why?
|
Cytokines | 1 | 2007 | 7317 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2007 | 13029 | 0.010 |
Why?
|
Postoperative Complications | 1 | 2014 | 15244 | 0.010 |
Why?
|
Cohort Studies | 1 | 2014 | 40450 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2009 | 19862 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2014 | 57683 | 0.010 |
Why?
|
Disease Progression | 1 | 2004 | 13256 | 0.000 |
Why?
|
Retrospective Studies | 1 | 2014 | 77098 | 0.000 |
Why?
|
Brain | 1 | 2009 | 26343 | 0.000 |
Why?
|
Aged | 1 | 2014 | 162944 | 0.000 |
Why?
|
Middle Aged | 1 | 2014 | 213127 | 0.000 |
Why?
|
Adult | 1 | 2014 | 213712 | 0.000 |
Why?
|
Concepts
(141)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(2)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_